Vor Biopharma reported cash from operations of -$25.38M and free cash flow of -$25.50M for the quarter ended Jun 2026, up 27.9% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -18.55M | -18.25M | -22.74M | -21.66M | -23.79M | -23.91M | -28.43M | -29.98M | -33.19M | -26.26M | -30.80M | -27.84M | -27.56M | -30.71M | -32.49M | -273.75M | -26.38M | -33.16M | -31.23M | -43.51M | ||||||
| Depreciation and Depletion | 1.50M | |||||||||||||||||||||||||
| Share-based Compensation | 2.48M | 1.20M | 6.38M | 1.91M | 3.33M | -0.83M | 4.07M | 4.24M | 3.16M | 1.89M | 3.13M | 3.05M | 2.64M | 1.71M | 4.88M | 7.51M | 82.30M | 7.11M | 109.80M | 107.30M | ||||||
| Gains from Investment Securities | 1,299.92M | 790.46M | -1756.02M | 188.36M | 19.30M | |||||||||||||||||||||
| Cash from Operations | -17.34M | -17.59M | -22.90M | -24.99M | -18.90M | -18.35M | -24.27M | -24.10M | -27.90M | -24.03M | -30.46M | -21.85M | -23.29M | -24.06M | -31.07M | -35.18M | -53.66M | -22.80M | -38.25M | -25.38M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 1.50M | |||||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Accured Expenses | 1.09M | 0.07M | -0.72M | -0.75M | 0.93M | 1.66M | -0.09M | 0.11M | 2.66M | 0.17M | -2.48M | 0.55M | 0.48M | 3.69M | -1.37M | 1.10M | 5.00M | 6.21M | -9.10M | 8.80M | ||||||
| Other Working Capital Changes | 1.47M | 0.83M | 1.74M | -8.78M | -2.00M | -1.42M | -0.73M | -1.48M | -0.43M | -0.94M | -0.92M | -0.92M | -0.97M | -1.02M | -1.05M | -1.58M | 0.07M | 0.15M | 6.36M | -0.28M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 0.64M | 1.17M | 3.54M | 4.30M | 0.30M | 0.32M | 0.09M | 0.40M | 0.47M | 0.11M | 0.11M | 0.01M | 0.03M | 0.07M | 0.23M | 0.15M | 0.24M | 0.31M | 0.05M | 0.12M | ||||||
| Change in Acquisitions & Divestments | 13.00M | 21.43M | 30.00M | 49.00M | 41.00M | 27.00M | 54.00M | 53.00M | 0.00M | -0.00M | 5.00M | 13.31M | 42.59M | |||||||||||||
| Cash from Investing Activities | -8.49M | -5.95M | -7.05M | -2.70M | 12.70M | -97.04M | 6.50M | 13.64M | 40.54M | 10.34M | 43.97M | 52.99M | -0.03M | -0.07M | -0.23M | 0.65M | -0.24M | -48.97M | -263.24M | -36.53M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | -0.00M | 0.20M | 0.10M | 0.23M | 0.01M | 55.55M | 175.00M | 75.00M | ||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.73M | 1.82M | 3.05M | 1.54M | 2.35M | 1.45M | 2.19M | 0.20M | 6.84M | 0.42M | ||||||||||||||||
| Net Equity Issued and Repurchased | 3.84M | 0.11M | 3.62M | 0.58M | 0.39M | -0.01M | 0.28M | -0.09M | 0.11M | -0.02M | 20.26M | 49.85M | ||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.20M | 0.31M | 0.20M | 0.60M | 4.08M | 112.26M | 2.52M | 0.22M | 0.18M | 0.03M | 0.10M | -0.03M | 0.04M | 53.29M | -0.61M | 175.06M | 21.55M | 307.80M | 74.87M | -0.11M | ||||||
| Change in Cash | -25.63M | -23.23M | -29.76M | -27.09M | -2.12M | -3.12M | -15.25M | -10.24M | 12.81M | -13.67M | 13.60M | 31.11M | -23.28M | 29.15M | -31.90M | 140.53M | -32.36M | 236.02M | -226.61M | -62.02M | ||||||
| Free Cash Flow | -17.98M | -18.75M | -26.44M | -29.30M | -19.20M | -18.67M | -24.36M | -24.50M | -28.36M | -24.14M | -30.58M | -21.86M | -23.32M | -24.14M | -31.30M | -35.34M | -53.91M | -23.11M | -38.29M | -25.50M | ||||||
| Net Cash Flow | -25.63M | -23.23M | -29.76M | -27.09M | -2.12M | -3.12M | -15.25M | -10.24M | 12.81M | -13.67M | 13.60M | 31.11M | -23.28M | 29.15M | -31.90M | 140.53M | -32.36M | 236.02M | -226.61M | -62.02M |